Pharmaceutical company buys Westminster-based Allos
Spectrum Pharmaceuticals is poised to land another cancer drug with its planned acquisition of Westminster-based Allos Therapeutics Inc. for up to $206 million cash, plus additiona
Spectrum Pharmaceuticals is poised to land another cancer drug with its planned acquisition of Westminster-based Allos Therapeutics Inc. for up to $206 million cash, plus additiona